Comparative efficacy of oral hypoglycemic agents to be added to biphasic insulin aspart-70 (BIAsp70) in Japanese type 2 diabetic patients by using continuous glucose monitoring system (CGMS)

Trial Profile

Comparative efficacy of oral hypoglycemic agents to be added to biphasic insulin aspart-70 (BIAsp70) in Japanese type 2 diabetic patients by using continuous glucose monitoring system (CGMS)

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2017

At a glance

  • Drugs Glimepiride (Primary) ; Metformin (Primary) ; Insulin aspart/insulin protamine aspart
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Sep 2017 Status changed from recruiting to completed.
    • 30 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top